ArticleInternational journal of molecular sciences2026
Apigenin as a Multitarget Anticancer Agent: Coordinated Inhibition of EGFR/MAPK and PI3K/Akt Signaling in Hematologic Malignancies.
Hatice Terzi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.